
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1.5B | -- | -- | -$0.05 | -- |
07/31/2025 | Q2 | $1.5B | -- | -- | -$0.12 | -- |
05/01/2025 | Q1 | $1.5B | $1.4B | -$0.03 | -$0.10 | $0.07 |
02/17/2025 | Q4 | $1.4B | $1.5B | -$0.82 | -$0.10 | -$0.72 |
11/04/2024 | Q3 | $1.5B | $1.5B | -$0.19 | $0.10 | -$0.29 |
08/05/2024 | Q2 | $1.6B | $1.6B | $0.13 | $0.14 | -$0.01 |
05/02/2024 | Q1 | $1.5B | $1.5B | -$0.22 | -$0.06 | -$0.16 |
02/22/2024 | Q4 | $1.4B | $1.4B | -$0.41 | -$0.15 | -$0.26 |
10/31/2023 | Q3 | -- | -- | -- | $0.19 | -- |
07/31/2023 | Q2 | -- | -- | $0.11 | $0.30 | -$0.19 |
05/05/2023 | Q1 | -- | -- | $0.83 | $0.14 | $0.69 |
02/21/2023 | Q4 | -- | -- | -$0.48 | $0.13 | -$0.61 |
11/04/2022 | Q3 | -- | -- | $0.50 | $0.71 | -$0.21 |
08/02/2022 | Q2 | -- | -- | $1.10 | $1.14 | -$0.04 |
04/28/2022 | Q1 | -- | -- | $1.04 | $1.02 | $0.02 |
02/15/2022 | Q4 | -- | -- | $2.73 | $0.90 | $1.83 |
10/29/2021 | Q3 | -- | -- | $0.94 | $0.92 | $0.02 |
07/30/2021 | Q2 | -- | -- | $0.70 | $0.81 | -$0.11 |
04/30/2021 | Q1 | -- | -- | $0.37 | $0.59 | -$0.22 |
02/12/2021 | Q4 | -- | -- | $1.54 | $0.46 | $1.08 |
10/29/2020 | Q3 | -- | -- | $0.22 | $0.27 | -$0.05 |
07/28/2020 | Q2 | -- | -- | -$0.28 | -$0.18 | -$0.10 |
05/01/2020 | Q1 | -- | -- | $3.16 | $0.18 | $2.98 |
02/13/2020 | Q4 | -- | -- | $1.34 | $0.29 | $1.05 |
10/25/2019 | Q3 | -- | -- | $0.13 | $0.44 | -$0.31 |
07/30/2019 | Q2 | -- | -- | $0.47 | $0.64 | -$0.17 |
04/30/2019 | Q1 | -- | -- | $0.51 | $0.41 | $0.10 |
02/12/2019 | Q4 | -- | -- | -$1.45 | $0.53 | -$1.98 |
10/30/2018 | Q3 | -- | -- | -$0.05 | $0.81 | -$0.86 |
07/31/2018 | Q2 | -- | -- | $1.71 | -- | -- |
05/01/2018 | Q1 | -- | -- | $1.11 | -- | -- |
02/23/2018 | Q4 | -- | -- | $1.01 | -- | -- |
10/27/2017 | Q3 | -- | -- | $0.60 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.69 | -- | -- |
04/26/2017 | Q1 | -- | -- | $0.31 | -- | -- |
02/15/2017 | Q4 | -- | -- | $0.53 | -- | -- |
10/28/2016 | Q3 | -- | -- | $0.23 | -- | -- |
07/27/2016 | Q2 | -- | -- | $0.36 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.24 | -- | -- |
02/11/2016 | Q4 | -- | -- | $0.02 | -- | -- |
10/27/2015 | Q3 | -- | -- | $0.22 | -- | -- |
Huntsman reported $1.4B worth of top line sales in its most recent quarter.
Huntsman announced earnings per share of -$0.03 which represents a beat of analyst forecast a -$0.10 per share.
Huntsman reported $201M that represents $1.17 per share over the last quarter.
Huntsman's earnings are forecast to decrease from -$1.10 per share to $0.07 per share next year representing a decrease of -60.86%.
Huntsman's next earnings date is July 31, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.